Clinical trial
Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism
NCT00211757 · Montefiore Medical Center, Other · Completed
Key facts
| NCT number | NCT00211757 |
|---|---|
| Title | Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism |
| Official title | Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism |
| Lead sponsor | Montefiore Medical Center, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug |
| Interventions | Divalproex sodium, Placebo |
| Enrollment | 27 |
| Start date | Sep 1, 2002 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 28, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: